Cytokinetics | CYTK - 流动负债



金融业
股票价格
USD
资产
USD 1.92B
现金及等价物
USD 255.27M
销售成本
USD 5.59M
流动资产
USD 1.21B
流动负债
USD 181.43M
债务
USD 1.29B
EBIT
USD -179.17M
EBITDA
USD -169.32M
员工
498
EPS每股收益
USD -1.5
股本和储备
USD -173.49M
销售毛利
USD 23.03M
债务利息支出
USD 34.83M
利息收入
USD 11.02M
贷款资金
USD 248.2M
市值
USD 7.69B
净收入
USD -198.76M
营业费用
USD 207.8M
营业利润
USD -179.17M
普通股股本
USD 124.43M
税前利润
USD -206.03M
销售收入
USD 28.6M
销售和管理费用
USD 104.4M
股票
USD 380K
贸易债权人
USD 20.51M
应收帐款人
USD 6.83M


流动负债 更改 日
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Amgen USD 25.5B 547M 2026-06
Arca Biopharma USD 22.97M 6.34M 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Biogen USD 3.92B 918.2M 2026-06
Brainstorm Cell Therapeutics USD 12.38M 621K 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Capricor Therapeutics USD 32.96M 676K 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
Eisai JPY 393.64B 53.39B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Exelixis USD 361.93M 9.05M 2026-06
Geron USD 70.33M 3.24M 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06